Literature DB >> 18162673

Surgical management of metastatic disease of the proximal femur.

H Hattori1, J Mibe, H Matsuoka, S Nagai, K Yamamoto.   

Abstract

PURPOSE: To review the surgical treatment for metastatic disease of the proximal femur.
METHODS: Records of 8 patients who underwent endoprosthetic replacement with tumour resection (group 1) and 8 others who underwent intramedullary nailing without tumour resection (group 2) were reviewed. Treatments were based on the disease progression and patient's condition.
RESULTS: In groups 1 and 2, the respective mean survival periods were 16 and 4 months. All patients in group 1 regained preoperative mobility, but only one patient in group 2 was able to walk with crutches.
CONCLUSION: This was a retrospective, rather than comparative study of endoprothetic replacement and intramedullary nailing for metastatic disease of the proximal femur. Both procedures are considered palliative, and not curative. The longer survival period in group 1 was mainly due to selection of patients with better preoperative medical status.

Entities:  

Mesh:

Year:  2007        PMID: 18162673     DOI: 10.1177/230949900701500310

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  5 in total

1.  What Are the Functional Results and Complications With Long Stem Hemiarthroplasty in Patients With Metastases to the Proximal Femur?

Authors:  Joel R Peterson; Alexander P Decilveo; Ian T O'Connor; Ivan Golub; James C Wittig
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

2.  Surgery for pathological proximal femoral fractures, excluding femoral head and neck fractures: resection vs. stabilisation.

Authors:  Max Zacherl; Gerald Gruber; Mathias Glehr; Petra Ofner-Kopeinig; Roman Radl; Manfred Greitbauer; Vilmos Vecsei; Reinhard Windhager
Journal:  Int Orthop       Date:  2010-12-01       Impact factor: 3.075

3.  Survival and outcomes of modular endoprosthetic reconstruction of the proximal femur for primary and non-primary bone tumors: Single institutional results.

Authors:  Charles A Gusho; Bishir Clayton; Nabil Mehta; Matthew W Colman; Steven Gitelis; Alan T Blank
Journal:  J Orthop       Date:  2021-05-07

4.  The burden of metastatic disease of the femur on the Medicare system.

Authors:  Kirollos Gendi; David Hennessy; John Heiner
Journal:  Springerplus       Date:  2016-11-04

5.  Distal Medullary Canal Decompression in Long Stem Hip Replacement in Long Bone Metastasis: Does it Reduce Cardiopulmonary Complications?

Authors:  Vivek Ajit Singh; Siamak Sarrafan; Ramesh Singh Veriah
Journal:  Indian J Orthop       Date:  2018 Jan-Feb       Impact factor: 1.251

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.